EAST WINDSOR, N.J. — Cushman & Wakefield has brokered the $4.7 million sale of a 27,992-square-foot industrial and life sciences building in East Windsor, located outside of Trenton in Central New Jersey. The building at 55 Lake Drive was constructed in 1974 (renovated in 2013) and was vacant at the time of sale. Dan Bottiglieri, Deb Boucher, Jordan Sobel, Andrew Schwartz, Andre Balthazard, Mike Dean and Kate Boyle of Cushman & Wakefield represented the seller, Danish biotechnology company Novonesis, in the transaction. The team also procured the undisclosed buyer.
MORRISVILLE, N.C. — JLL has arranged $237.7 million loan for Phase I of Pathway Triangle, a life sciences campus underway in North Carolina’s Research Triangle Park (RTP). Phase I comprises four life sciences and advanced manufacturing buildings totaling 581,789 square feet on McCrimmon Parkway in Morrisville, about 14 miles west of Raleigh. Brett Paulsrud, Amy Lousararian, Andrew Gray, Ward Smith, Hugh Doherty and Libby Horton of JLL arranged the loan through Starwood Property Trust on behalf of the borrower, King Street Properties. Two buildings totaling 377,111 square feet have been completed at Pathway Triangle and are 73 percent leased. Building 1 is partially leased to Liquidia Pharmaceuticals for the manufacturing of Yutrepia, an FDA-approved inhalation powder treating pulmonary arterial hypertension. Building 2 is fully leased to Novartis. Construction began recently on the other two Phase I buildings — Building 4 (148,434 square feet) and Building 7 (56,244 square feet), which is fully preleased to Novartis. A second phase is planned for Pathway Triangle, upon completion of which the campus will span 950,000 square feet.
ATLANTA — The Duracell Co. has relocated its Global Headquarters for Research and Development to Science Square Labs, a 368,213-square-foot laboratory and office tower in Midtown Atlanta. Duracell’s relocation from Bethel, Conn., stems from a multi-year initiative first announced by Georgia officials in February 2025. The project represents a $56 million investment and is projected to generate 100 new jobs in the state. The facility is officially open and operational following a ribbon-cutting ceremony attended by Mayor Andre Dickens. The Atlanta center serves as Duracell’s global innovation hub, where scientists and engineers work across materials science, cell design, laboratory prototyping and device characterization to advance battery performance, quality and safety. Phase I of Science Square, which is anchored by the 13-story Science Square Labs, was delivered in 2025. At full build-out, the district’s master plan allows for approximately 1.8 million square feet of lab and office space, 500 residences and 25,000 square feet of retail space. Additional tenants at Science Square Labs include Georgia Tech and Emory biomedical engineering faculty labs, a Shriners Children’s research institute and utility infrastructure services company Osmose. Science Square Labs is developed and owned by the Trammell Crow Company (TCC) in a joint venture with Georgia …
BILLERICA, MASS. —Berkeley Garbe, a Boston-based developer that is a joint venture between Berkeley Investments and German real estate company GARBE, is underway on construction of a 150,000-square-foot life sciences project in Billerica, located northwest of the state capital. The site spans 23 acres at 161 Concord Road, and the new building will support manufacturers in industries such as aerospace, robotics, medical devices, semiconductors, computer hardware and battery technologies. Building features will include a clear height of 28 feet and 264 car parking spaces. Avison Young is the leasing agent for the project. Construction began in June and is expected to be complete next spring, and Berkeley Garbe has since received an additional $35.4 million in financing for the project from MetLife Investment Management. Andrew Kaeyer led a capital markets team at Hunneman that arranged the debt of behalf of the developer.
ANDOVER, MASS. — AdvanCell has signed a 128,000-square-foot life sciences lease in the northern Boston suburb of Andover. The clinical-stage radiopharmaceutical company will occupy the entirety of the building at 1 Corporate Drive, which is located within Innovation Park, a 340,000-square-foot development. The deal brings Phase II of Innovation Park, which is owned by life sciences REIT IQHQ, to full occupancy. Information on third-party brokers who were involved in the lease negotiations was not disclosed.
HOLLY SPRINGS, N.C. — Genentech, a biotechnology company and member of the Roche Group, has topped out its new $2 billion manufacturing facility in Holly Springs, about 20 miles southwest of Raleigh. The construction milestone marks the completion of the building’s structural framework. The project is Genentech’s first East Coast manufacturing facility. The development was initially announced in May 2025, followed by the groundbreaking in August 2025 and an expansion announcement in January 2026. Once operational, the facility will produce next-generation treatments for metabolic conditions such as obesity. Its operations will incorporate advanced biomanufacturing, automation, robotics and the latest digital manufacturing technologies. The investment in technology includes an advanced digital twin — an artificial intelligence-powered virtual model of the manufacturing facility designed to simulate operations and test scenarios before real-world implementation. The facility is expected to support more than 2,000 jobs, including 500 manufacturing roles and 1,500 construction jobs. Genentech is also partnering with local academic institutions to prepare future members of the workforce for manufacturing careers. The project is part of Switzerland-based Roche and Genentech’s broader $50 billion commitment to research and development (R&D) and manufacturing infrastructure in the United States. Roche and Genentech’s current U.S. footprint includes 13 …
EVERETT, WASH. — Breakthrough, a joint venture of Tishman Speyer and Bellco Capital, has acquired a biomanufacturing facility in Everett, a suburb of Seattle, for $78 million. In tandem with the acquisition, Breakthrough secured a separate 21-year lease for the entire campus with a global biopharmarceutical company to create a U.S. manufacturing facility. The 270,000-square-foot facility can support a range of uses, including drug manufacturing, quality-control lab operations and, warehouse/distribution functions. The property also offers administrative office spaces and an onsite café. The site, located at 215 Shuksan Way, was originally leased to a biotechnology company that invested approximately $350 million to build out a biomanufacturing facility but never moved in after being acquired in 2023. The transaction marks Breakthrough’s first investment in the Puget Sound region. The name of the seller was not released.
TOPEKA, KAN. — Spore.Bio, a biotechnology company headquartered in France with an existing U.S. presence in New York, has unveiled plans to become the first laboratory tenant at Link Innovation Labs in Topeka. Located in the heart of Topeka’s Innovation District, Link Innovation Labs provides flexible private lab suites, shared equipment, collaboration areas and resources designed to help companies accelerate research, commercialization and growth. Organizations located within Link Innovation Labs include Plug and Play Topeka, the Washburn Small Business Development Center and Sparrow Coffee at Link.
HOUSTON — Bristol Myers Squibb (NYSE: BMY), a global pharmaceutical company best known for manufacturing treatments and medications such as Opdivo and Eliquis, will open a $2.3 billion manufacturing campus in Houston. The Princeton, N.J.-based firm chose a site within McCord Development’s 4,300-acre Generation Park for the approximately 600,000-square-foot project. “This investment reflects our confidence in America’s continued leadership in biopharmaceutical innovation,” says Christopher Boerner, board chair and CEO of Bristol Myers Squibb. “As part of our $40 billion commitment to the United States, we’re building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure and partnership needed to help bring that vision to life.” Situated in northeast Houston, Bristol Myers Squibb’s new campus will be designed to be both modular and multi-modal, allowing the company to reconfigure manufacturing capacity for multiple types of medicines — including small molecules, biologics and antibody-drug conjugates — as needs arise. The new campus is estimated to create nearly 500 skilled jobs in the Houston area for roles including operations technicians, production specialists, maintenance and engineering professionals, quality control/assurance experts and administration. Bristol Myers Squibb also anticipates …
ELIZABETH, N.J. — Osmo, which uses machine learning to digitize scent and promote olfactory science, has opened a 60,000-square-foot headquarters facility in the Northern New Jersey community of Elizabeth. Designed by KSS Architects, the facility includes office, lab and manufacturing space, as well as a breakout room, café and shared spaces to foster cross-disciplinary collaboration. A partnership between Bridge Industrial and Elberon Development Group owns the building, the address of which was not disclosed.
Newer Posts